Clinical impact of FDG-PET on the management of esophageal cancer

2004 ◽  
Vol 11 (S2) ◽  
pp. S53-S54 ◽  
Author(s):  
C. P. Duong ◽  
H. Demitriou ◽  
A. Thompson ◽  
L. Weih ◽  
W. A. Phillips ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Fdg Pet ◽  
Clinical Impact

scholarly journals 18F-FDG PET/CT Parameters for Predicting Prognosis in Esophageal Cancer Patients Treated With Concurrent Chemoradiotherapy

2021 ◽  
Vol 20 ◽  
pp. 153303382110246
Author(s):  
Seokmo Lee ◽  
Yunseon Choi ◽  
Geumju Park ◽  
Sunmi Jo ◽  
Sun Seong Lee ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Cancer Patients ◽  
Fdg Pet ◽  
Concurrent Chemoradiotherapy ◽  
Curative Intent ◽  
Squamous Cell Esophageal Cancer ◽  
Pet Ct ◽  
Significant Difference ◽  
Fdg Pet Ct

Background and Aims: This study evaluated the prognostic value of 18F-fluorodeoxyglucose positron emission tomography with integrated computed tomography (18F-FDG PET/CT) performed before and after concurrent chemoradiotherapy (CCRT) in esophageal cancer. Methods: We analyzed the prognosis of 50 non-metastatic squamous cell esophageal cancer (T1-4N0-2) patients who underwent CCRT with curative intent at Inje University Busan Paik Hospital and Haeundae Paik Hospital from 2009 to 2019. Median total radiation dose was 54 Gy (range 34-66 Gy). Our aim was to investigate the relationship between PET/CT values and prognosis. The primary end point was progression-free survival (PFS). Results: The median follow-up period was 9.9 months (range 1.7-85.7). Median baseline maximum standard uptake value (SUVmax) was 14.2 (range 3.2-27.7). After treatment, 29 patients (58%) showed disease progression. The 3-year PFS and overall survival (OS) were 24.2% and 54.5%, respectively. PFS was significantly lower ( P = 0.015) when SUVmax of initial PET/CT exceeded 10 (n = 22). However, OS did not reach a significant difference based on maximum SUV ( P = 0.282). Small metabolic tumor volume (≤14.1) was related with good PFS ( P = 0.002) and OS ( P = 0.001). Small total lesion of glycolysis (≤107.3) also had a significant good prognostic effect on PFS ( P = 0.009) and OS ( P = 0.025). In a subgroup analysis of 18 patients with follow-up PET/CT, the patients with SUV max ≤3.5 in follow-up PET/CT showed longer PFS ( P = 0.028) than those with a maximum SUV >3.5. Conclusion: Maximum SUV of PET/CT is useful in predicting prognosis of esophageal cancer patients treated with CCRT. Efforts to find more effective treatments for patients at high risk of progression are still warranted.

scholarly journals Dose escalation guided by F-FDG PET/CT for esophageal cancer

2021 ◽  
Author(s):  
Bingjie Fan ◽  
Chengqiang Li ◽  
Fengchun Mu ◽  
Wenru Qin ◽  
Linlin Wang ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Dose Escalation ◽  
Fdg Pet ◽  
Pet Ct ◽  
Fdg Pet Ct

scholarly journals Intratumoral Metabolic Heterogeneity and Other Quantitative 18F-FDG PET/CT Parameters for Prognosis Prediction in Esophageal Cancer

2021 ◽  
Vol 3 (1) ◽  
pp. e200022
Author(s):  
Akilan Gopal ◽  
Yin Xi ◽  
Rathan M. Subramaniam ◽  
Daniella F. Pinho
Keyword(s):  
Esophageal Cancer ◽  
Fdg Pet ◽  
Prognosis Prediction ◽  
Pet Ct ◽  
18F Fdg ◽  
Metabolic Heterogeneity ◽  
Fdg Pet Ct

scholarly journals FDG-PET/CT in high-risk primary breast cancer—a prospective study of stage migration and clinical impact

2020 ◽  
Author(s):  
Marianne Vogsen ◽  
Jeanette Dupont Jensen ◽  
Ivar Yannick Christensen ◽  
Oke Gerke ◽  
Anne Marie Bak Jylling ◽  
...  
Keyword(s):  
Breast Cancer ◽  
High Risk ◽  
Prospective Study ◽  
Fdg Pet ◽  
Primary Breast Cancer ◽  
Clinical Impact ◽  
Stage Migration ◽  
Pet Ct ◽  
A Prospective Study ◽  
Fdg Pet Ct

scholarly journals Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer

2012 ◽  
Vol 104 (1) ◽  
pp. 72-77 ◽  
Author(s):  
Andre Konski ◽  
Tianyu Li ◽  
Michael Christensen ◽  
Jonathan D. Cheng ◽  
Jian Q. Yu ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Fdg Pet ◽  
Cardiac Toxicity ◽  
Patient Factors ◽  
18F Fdg

scholarly journals Erratum to: Advantages of FDG-PET/CT over CT alone in the preoperative assessment of lymph node metastasis in patients with esophageal cancer

Surgery Today ◽  
2015 ◽  
Vol 45 (4) ◽  
pp. 478-478
Author(s):  
Ryuichi Karashima ◽  
Masayuki Watanabe ◽  
Yu Imamura ◽  
Satoshi Ida ◽  
Yoshifumi Baba ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Lymph Node ◽  
Lymph Node Metastasis ◽  
Fdg Pet ◽  
Preoperative Assessment ◽  
Node Metastasis ◽  
Pet Ct ◽  
Fdg Pet Ct

Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma

2007 ◽  
Vol 78 (3) ◽  
pp. 206-212 ◽  
Author(s):  
Martin Hutchings ◽  
Annika Loft ◽  
Mads Hansen ◽  
Anne Kiil Berthelsen ◽  
Lena Specht
Keyword(s):  
Hodgkin Lymphoma ◽  
Fdg Pet ◽  
Early Stage ◽  
Clinical Impact ◽  
Pet Ct ◽  
Fdg Pet Ct

Radiation-induced liver injury mimicking liver metastases on FDG-PET-CT after chemoradiotherapy for esophageal cancer

2017 ◽  
Vol 194 (2) ◽  
pp. 156-163 ◽  
Author(s):  
Francine E. M. Voncken ◽  
Berthe M. P. Aleman ◽  
Jolanda M. van Dieren ◽  
Cecile Grootscholten ◽  
Ferry Lalezari ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Liver Injury ◽  
Liver Metastases ◽  
Fdg Pet ◽  
Pet Ct ◽  
Radiation Induced ◽  
Fdg Pet Ct
Sign in / Sign up

Export Citation Format

Share Document